Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 08:08 am Purchase | 2025-06-30 | 13G | Tarsus Pharmaceuticals, Inc. TARS | RTW Investments, LP | 3,424,180 8.100% | 271,839 (+8.62%) | Filing History |
| 2025-08-14 08:07 am Purchase | 2025-06-30 | 13G | Exagen Inc. XGN | RTW Investments, LP | 1,696,866 7.700% | 192,264 (+12.78%) | Filing History |
| 2025-08-14 08:05 am Purchase | 2025-06-30 | 13G | COMPASS Pathways plc CMPS | RTW Investments, LP | 9,474,397 9.900% | 9,474,397 (New Position) | Filing History |
| 2025-08-14 08:04 am Sale | 2025-06-30 | 13G | CARGO Therapeutics, Inc. Common Stock CRGX | RTW Investments, LP | 3,055,063 6.400% | -2,886,393 (-48.58%) | Filing History |
| 2025-08-14 08:02 am Sale | 2025-06-30 | 13G | Axsome Therapeutics, Inc. AXSM | RTW Investments, LP | 1,516,903 3.100% | -1,405,826 (-48.10%) | Filing History |
| 2025-08-14 08:00 am Sale | 2025-06-30 | 13G | Akero Therapeutics, Inc. AKRO | RTW Investments, LP | 5,873,308 7.300% | -986,515 (-14.38%) | Filing History |
| 2025-08-06 4:29 pm Unchanged | 2025-08-04 | 13D | Orchestra BioMed Holdings, Inc. OBIO | RTW Investments, LP | 8,306,063 15.400% | 0 (Unchanged) | Filing History |
| 2025-05-15 08:34 am Purchase | 2025-03-31 | 13G | Tenax Therapeutics, Inc. TENX | RTW Investments, LP | 418,440 9.990% | 418,440 (New Position) | Filing History |
| 2025-05-15 08:29 am Sale | 2025-03-31 | 13G | 89bio, Inc. ETNB | RTW Investments, LP | 1,967,527 1.300% | -5,411,021 (-73.33%) | Filing History |
| 2025-05-15 08:26 am Purchase | 2025-03-31 | 13G | GH Research PLC GHRS | RTW Investments, LP | 5,499,769 8.900% | 2,172,640 (+65.30%) | Filing History |
| 2025-05-15 08:22 am Sale | 2025-03-31 | 13G | PepGen Inc. PEPG | RTW Investments, LP | 0 0.000% | -3,193,097 (Position Closed) | Filing History |
| 2025-05-15 08:17 am Sale | 2025-03-31 | 13G | Dyne Therapeutics, Inc. DYN | RTW Investments, LP | 1,690,567 1.500% | -3,528,074 (-67.61%) | Filing History |
| 2025-05-15 08:15 am Purchase | 2025-03-31 | 13G | Beta Bionics, Inc. BBNX | RTW Investments, LP | 3,299,869 7.600% | 3,299,869 (New Position) | Filing History |
| 2025-05-15 08:09 am Sale | 2025-03-31 | 13G | Axsome Therapeutics, Inc. AXSM | RTW Investments, LP | 2,922,729 6.000% | -1,128,636 (-27.86%) | Filing History |
| 2025-05-15 08:07 am Purchase | 2025-03-31 | 13G | Verastem, Inc. VSTM | RTW Investments, LP | 4,245,476 8.300% | 4,245,476 (New Position) | Filing History |
| 2025-05-15 08:00 am Sale | 2025-03-31 | 13G | Immunic, Inc. IMUX | RTW Investments, LP | 1,026,762 1.100% | -4,567,717 (-81.65%) | Filing History |
| 2025-05-15 08:00 am Purchase | 2025-03-31 | 13G | Taysha Gene Therapies, Inc. TSHA | RTW Investments, LP | 20,673,307 9.990% | 8,304,973 (+67.15%) | Filing History |
| 2025-05-15 08:00 am Purchase | 2025-03-31 | 13G | Oruka Therapeutics, Inc. ORKA | RTW Investments, LP | 1,945,649 5.200% | 1,945,649 (New Position) | Filing History |
| 2025-05-15 08:00 am Purchase | 2025-03-31 | 13G | COMPASS Pathways plc CMPS | RTW Investments, LP | 7,877,349 8.300% | 7,877,349 (New Position) | Filing History |
| 2025-05-15 08:00 am Purchase | 2025-03-31 | 13G | uniQure N.V. QURE | RTW Investments, LP | 4,265,428 7.900% | 4,265,428 (New Position) | Filing History |